These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


538 related items for PubMed ID: 28722110

  • 1. Renal-infiltrating CD11c+ cells are pathogenic in murine lupus nephritis through promoting CD4+ T cell responses.
    Liao X, Ren J, Reihl A, Pirapakaran T, Sreekumar B, Cecere TE, Reilly CM, Luo XM.
    Clin Exp Immunol; 2017 Nov; 190(2):187-200. PubMed ID: 28722110
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, Koyro T, Peters A, Velden J, Hünemörder S, Haag F, Steinmetz OM, Mittrücker HW, Stahl RA, Panzer U.
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [Abstract] [Full Text] [Related]

  • 4. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.
    Spada R, Rojas JM, Pérez-Yagüe S, Mulens V, Cannata-Ortiz P, Bragado R, Barber DF.
    J Leukoc Biol; 2015 Mar; 97(3):583-98. PubMed ID: 25583577
    [Abstract] [Full Text] [Related]

  • 5. ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.
    Odegard JM, DiPlacido LD, Greenwald L, Kashgarian M, Kono DH, Dong C, Flavell RA, Craft J.
    J Immunol; 2009 Apr 01; 182(7):4076-84. PubMed ID: 19299705
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis.
    Rose A, von Spee-Mayer C, Kloke L, Wu K, Kühl A, Enghard P, Burmester GR, Riemekasten G, Humrich JY.
    Cells; 2019 Oct 11; 8(10):. PubMed ID: 31614462
    [Abstract] [Full Text] [Related]

  • 8. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W, Zheng H, Wu S, Zhang Y, Wang W, Zhang Z, Zhou C, Wu H, Min J.
    Am J Nephrol; 2017 Oct 11; 46(5):371-379. PubMed ID: 29069649
    [Abstract] [Full Text] [Related]

  • 9. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 10. Cordyceps protein alleviates renal injury by inhibiting T cell infiltration and Th1 cell differentiation in lupus nephritis mice.
    Liao Z, Yang X, He L, Bai J, Zhou X, Yang J, Niu S, Liu S, Guo J.
    Int Immunopharmacol; 2024 Sep 10; 138():112566. PubMed ID: 38943968
    [Abstract] [Full Text] [Related]

  • 11. Infiltrating dendritic cells contribute to local synthesis of C1q in murine and human lupus nephritis.
    Castellano G, Trouw LA, Fiore N, Daha MR, Schena FP, van Kooten C.
    Mol Immunol; 2010 Jul 10; 47(11-12):2129-37. PubMed ID: 20417969
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophages.
    Klocke J, Kopetschke K, Grießbach AS, Langhans V, Humrich JY, Biesen R, Dragun D, Radbruch A, Burmester GR, Riemekasten G, Enghard P.
    Eur J Immunol; 2017 Jan 10; 47(1):180-192. PubMed ID: 27753073
    [Abstract] [Full Text] [Related]

  • 14. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18.
    Tucci M, Quatraro C, Lombardi L, Pellegrino C, Dammacco F, Silvestris F.
    Arthritis Rheum; 2008 Jan 10; 58(1):251-62. PubMed ID: 18163476
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.
    J Rheumatol; 2010 Jan 10; 37(1):60-70. PubMed ID: 19955044
    [Abstract] [Full Text] [Related]

  • 16. A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis.
    Parikh SV, Malvar A, Shapiro J, Turman JM, Song H, Alberton V, Lococo B, Mejia-Vilet JM, Madhavan S, Zhang J, Yu L, Satoskar AA, Birmingham D, Jarjour WN, Rovin BH, Ganesan LP.
    Front Immunol; 2021 Jan 10; 12():621039. PubMed ID: 33659005
    [Abstract] [Full Text] [Related]

  • 17. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.
    Lema GP, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, Schlöndorff D.
    J Am Soc Nephrol; 2001 Jul 10; 12(7):1369-1382. PubMed ID: 11423566
    [Abstract] [Full Text] [Related]

  • 18. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.
    Enghard P, Humrich JY, Rudolph B, Rosenberger S, Biesen R, Kuhn A, Manz R, Hiepe F, Radbruch A, Burmester GR, Riemekasten G.
    Arthritis Rheum; 2009 Jan 10; 60(1):199-206. PubMed ID: 19116922
    [Abstract] [Full Text] [Related]

  • 19. Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.
    Ramanujam M, Steffgen J, Visvanathan S, Mohan C, Fine JS, Putterman C.
    Autoimmun Rev; 2020 Nov 10; 19(11):102668. PubMed ID: 32942031
    [Abstract] [Full Text] [Related]

  • 20. Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice.
    Zhou G, Fujio K, Sadakata A, Okamoto A, Yu R, Yamamoto K.
    Clin Exp Immunol; 2004 Jun 10; 136(3):448-55. PubMed ID: 15147346
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.